These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35507153)

  • 1. Generation of Human iPSC from Small Volume Peripheral Blood Samples.
    Kloos D; Lachmann N
    Methods Mol Biol; 2022; 2429():27-39. PubMed ID: 35507153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
    Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
    Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a control human induced pluripotent stem cell line using the defective and persistent Sendai virus vector system.
    Zhou Z; Yoshimatsu S; Qian E; Ishikawa M; Sato T; Ohtaka M; Nakanishi M; Okano H
    Stem Cell Res; 2021 Oct; 56():102549. PubMed ID: 34598113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
    Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
    Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector.
    Sommer AG; Rozelle SS; Sullivan S; Mills JA; Park SM; Smith BW; Iyer AM; French DL; Kotton DN; Gadue P; Murphy GJ; Mostoslavsky G
    J Vis Exp; 2012 Oct; (68):. PubMed ID: 23149977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Human Induced Pluripotent Stem Cells from Multiple Sclerosis Patients.
    Begentas OC; Koc D; Kiris E
    Methods Mol Biol; 2022; 2549():43-67. PubMed ID: 34988943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized Sendai viral vector platform for reprogramming to naive pluripotency.
    Charlesworth CT; Nakauchi H
    Cell Rep Methods; 2022 Nov; 2(11):100349. PubMed ID: 36452874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
    Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
    Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector.
    Ono M; Hamada Y; Horiuchi Y; Matsuo-Takasaki M; Imoto Y; Satomi K; Arinami T; Hasegawa M; Fujioka T; Nakamura Y; Noguchi E
    PLoS One; 2012; 7(8):e42855. PubMed ID: 22912751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.
    Wen W; Zhang JP; Chen W; Arakaki C; Li X; Baylink D; Botimer GD; Xu J; Yuan W; Cheng T; Zhang XB
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
    Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
    Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol.
    Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X
    Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.